Reach Us +1-217-403-9671
SNPs And Drug Response: How To Separate The Wheat From The Chaff | 3776
ISSN: 0974-276X

Journal of Proteomics & Bioinformatics
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

SNPs and drug response: How to separate the wheat from the chaff

2nd International Conference on Proteomics & Bioinformatics

Evgeny Krynetskiy

Accepted Abstracts: J Proteomics Bioinform

DOI: 10.4172/0974-276X.S1.065

Identification of genetic biomarkers that define a specific pharmacogenetic phenotype presents a complex problem of Pharmacogenomics. Several approaches have been found useful to select genetic markers which accurately predict drug response or adverse drug reactions. The general strategy includes the search for statistical association between SNPs and the phenotype. Using a prokinetic drug domperidone as an example, the major approaches to identification of SNPs important for effective and safe use of this drug will be outlined. Analysis of candidate genes presumed to contribute to domperidone pharmacotherapeutic effects, along with genome-wide genotyping helped to generate lists of SNPs associated with domperidone effects. Hard biological evidence is required to identify the causal genetic polymorphisms. The limitations and prospects of the pharmacogenetic analysis will be discussed. The combination of gene-based diagnostics, biological evidence, and data mining has the potential to make Pharmacogenomics an efficient tool of practical medicine.
Leave Your Message 24x7